ProfileGDS5822 / ILMN_2914453
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 69% 76% 75% 64% 75% 76% 80% 69% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 14769
GSM1276600PDAC Late Ablation Control 2100.276
GSM1276601PDAC Late Ablation Control 3121.675
GSM1276602PDAC Late Ablation 131.564
GSM1276603PDAC Late Ablation 287.875
GSM1276604PDAC Late Ablation 3107.276
GSM1303940PDAC Late Ablation_anti-CTLA4 1132.180
GSM1303941PDAC Late Ablation_anti-CTLA4 262.969
GSM1303942PDAC Late Ablation_anti-CTLA4 3106.275